Truist Securities Maintains Hold on GoodRx Holdings, Raises Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has maintained a Hold rating on GoodRx Holdings (NASDAQ:GDRX) and increased the price target from $7.5 to $8.

March 01, 2024 | 1:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities maintains a Hold rating on GoodRx Holdings and raises the price target from $7.5 to $8.
The increase in price target by Truist Securities suggests a positive outlook on GoodRx Holdings' stock value in the short term. Although the rating remains a Hold, the adjustment in price target indicates an expectation of some upward movement in the stock price, likely leading to a positive short-term impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100